Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
124.15
+1.23 (1.00%)
At close: Mar 31, 2025, 4:00 PM
120.81
-3.34 (-2.69%)
Pre-market: Apr 1, 2025, 8:15 AM EDT
Jazz Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 560.12 | 414.83 | -224.06 | -329.67 | 238.62 | Upgrade
|
Depreciation & Amortization | 660.07 | 638.7 | 629.47 | 552.48 | 278.25 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | 37.7 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 10 | 80.01 | 577.8 | - | 387.39 | Upgrade
|
Loss (Gain) on Equity Investments | - | - | - | - | 5.44 | Upgrade
|
Stock-Based Compensation | 248.05 | 226.84 | 222 | 189.01 | 121 | Upgrade
|
Provision & Write-off of Bad Debts | 27.76 | 11.11 | 14.54 | 19.67 | 15 | Upgrade
|
Other Operating Activities | -33.36 | -75.05 | 4.63 | 394.97 | -60.61 | Upgrade
|
Change in Accounts Receivable | -21.12 | -51.88 | -90.14 | -92.74 | -38.65 | Upgrade
|
Change in Inventory | -45.54 | -13.42 | -49.64 | -48.86 | -30.54 | Upgrade
|
Change in Accounts Payable | -20.07 | 9.6 | -11.23 | 57.02 | -18.94 | Upgrade
|
Change in Unearned Revenue | - | -0.46 | -2.09 | -2.31 | -4.72 | Upgrade
|
Change in Income Taxes | -14.74 | 25.22 | -1.69 | -15.52 | 13.04 | Upgrade
|
Change in Other Net Operating Assets | 24.75 | -173.5 | 164.69 | 54.45 | -5.64 | Upgrade
|
Operating Cash Flow | 1,396 | 1,092 | 1,272 | 778.51 | 899.65 | Upgrade
|
Operating Cash Flow Growth | 27.83% | -14.15% | 63.39% | -13.46% | 15.87% | Upgrade
|
Capital Expenditures | -38.07 | -23.96 | -29.05 | -27.64 | -15 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | 14.26 | Upgrade
|
Cash Acquisitions | - | - | - | -6,235 | - | Upgrade
|
Divestitures | - | - | 53 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -10 | -19 | -469.15 | -17.89 | -364.25 | Upgrade
|
Investment in Securities | -460.13 | -120.1 | -1.04 | 1,068 | -642.68 | Upgrade
|
Investing Cash Flow | -508.2 | -163.06 | -446.23 | -5,212 | -1,008 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 500 | Upgrade
|
Long-Term Debt Issued | 980.77 | - | - | 5,191 | 981.38 | Upgrade
|
Total Debt Issued | 980.77 | - | - | 5,191 | 1,481 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -500 | Upgrade
|
Long-Term Debt Repaid | -606 | -31 | -582.01 | -1,321 | -389.58 | Upgrade
|
Total Debt Repaid | -606 | -31 | -582.01 | -1,321 | -889.58 | Upgrade
|
Net Debt Issued (Repaid) | 374.77 | -31 | -582.01 | 3,871 | 591.81 | Upgrade
|
Issuance of Common Stock | 20.65 | 46.46 | 98.02 | 135.26 | 99.68 | Upgrade
|
Repurchase of Common Stock | -369.18 | -320.71 | -45.5 | -35.6 | -163.41 | Upgrade
|
Other Financing Activities | -5.72 | - | - | - | - | Upgrade
|
Financing Cash Flow | 20.52 | -305.25 | -529.49 | 3,971 | 528.07 | Upgrade
|
Foreign Exchange Rate Adjustments | -1.68 | 1.14 | -6.22 | -3.21 | 0.37 | Upgrade
|
Net Cash Flow | 906.55 | 624.83 | 290.03 | -466.32 | 420.43 | Upgrade
|
Free Cash Flow | 1,358 | 1,068 | 1,243 | 750.87 | 884.64 | Upgrade
|
Free Cash Flow Growth | 27.13% | -14.07% | 65.53% | -15.12% | 20.15% | Upgrade
|
Free Cash Flow Margin | 33.37% | 27.86% | 33.97% | 24.27% | 37.43% | Upgrade
|
Free Cash Flow Per Share | 20.57 | 14.82 | 19.87 | 12.58 | 15.65 | Upgrade
|
Cash Interest Paid | 314.82 | 333.11 | 270.67 | 138.27 | 42.47 | Upgrade
|
Cash Income Tax Paid | 114.91 | 177.88 | 94.68 | 271.22 | 226.82 | Upgrade
|
Levered Free Cash Flow | 1,434 | 1,053 | 1,125 | -138.27 | 347.89 | Upgrade
|
Unlevered Free Cash Flow | 1,649 | 1,275 | 1,312 | 37.09 | 417.15 | Upgrade
|
Change in Net Working Capital | -250.63 | 54.64 | -434.18 | 955.91 | 81.26 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.